07:00 , Oct 8, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Eukaryotic translation initiation factor 6 (eIF6)

Endocrine/metabolic disease INDICATION: Obesity Studies in mice and human blood and tissue samples suggest inhibiting eIF6 could help treat obesity. In blood and adipose tissue samples from 33 healthy adults, insulin sensitivity negatively correlated with eIF6 levels...